Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Association of Treg/CD4+ with clinical characteristics

From: Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection

Clinical characteristics Treg/CD4+ <5.07 % Treg/CD4 ≥ 5.07 % P
Age (y) ≤50 16 7 0.040*
>50 24 2
Sex Male 13 0 0.046*
Female 27 9
HBsAg Negative 8 1 0.534
Postive 32 8
HBeAg Negative 30 6 0.609
Postive 10 3
HBVDNA <5*102 25 6 0.815
>5*102 15 3
Child-Pugh score A 39 9 0.632
B 1 0
Liver cirrhosis No 10 2 0.861
Yes 30 7
ALT (U/L) ≤75 26 7 0.460
>75 14 2
AFP (ng/ml) ≤400 32 7 0.881
>400 8 2
Tumor number Single 36 8 0.921
Multiple 4 1
Tumor size (cm) ≤5 25 4 0.319
>5 15 5
Tumor encapsulation Complete 17 4 0.915
None 23 5
Satellite lesion No 38 6 0.011*
Yes 2 3
Vascular invasion No 22 3 0.240
Yes 18 6
Edmondson stage I-II 25 6 0.815
II-IV 15 3
BCLC stage 0 + A 37 7 0.187
B + C 3 2
  1. p value of < 0.05 was considered statistically-significant